DR REDDYS LABORATORIES LTD (NYSE: RDY) allotted 375 fully paid equity shares on September 10, 2026, following eligible employee exercises under its stock option programme. The shares rank equally with existing equity.
Elevance Health, Inc. (NYSE: ELV) is reaffirming full-year 2026 shareholders’ earnings guidance of at least $20.10 per diluted share.
EXELIXIS, INC. (NASDAQ: EXEL) said the FDA extended its review of zanzalintinib with atezolizumab for metastatic colorectal cancer by three months.
GeoVax Labs, Inc. (NASDAQ: GOVX) will appeal its Nasdaq delisting determination at a Hearings Panel session scheduled for October 13, 2026.
Gossamer Bio, Inc. (NASDAQ: GOSS) completed a 1-for-80 reverse stock split, converting every 80 outstanding common shares into one share. The move is intended to help the stock meet Nasdaq’s $1.00 minimum closing bid requirement before the October 5 compliance date.
IceCure Medical Ltd. (NASDAQ: ICCM) can market its ProSense system in China after receiving approval from the National Medical Products Administration on September 10, 2026. The authorization covers the system and its associated cryoprobes under the approved registration.
AtaiBeckley Inc. (NASDAQ: ATAI) completed its merger with Eli Lilly and Company (NYSE: LLY) on September 11, 2026, becoming aWholly Owned Subsidiaryof Lilly. Each eligible common share converted into $6.75 in cash plus one contingent value right that can pay up to $2.50 per …
Axogen, Inc. (NASDAQ: AXGN) agreed to acquire BioCircuit Technologies for a base cash purchase price of $200.0 million. The transaction would make BioCircuit a wholly owned subsidiary, while Axogen intends to use substantially all net proceeds from a common-stock offering to fund the cash …
BetterLife Pharma Inc. (OTC: BETRF) appointed Charles Duncan, PhD, as a director and chair of its audit committee in August 2026. The appointment came with 500,000 stock options exercisable at $0.285 per share, alongside a further option grant carrying the same exercise price.
BioCardia, Inc. (NASDAQ: BCDA) will present its CardiAMP program and related technology platforms at the H.C. Wainwright conference beginning September 14 in New York.